Inhalation Capsules Market Players:
- Cipla
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GSK(GlaxoSmithKline)
- Hovione
- Chiesi
- Iconovo
- Novartis
- ACG
- Norton Healthcare
- Capsugel
- OPKO
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of inhalation capsules is estimated at USD 1.13 billion.
The global inhalation capsules market size was more than USD 1.06 billion in 2025 and is anticipated to witness a CAGR of around 7.5%, crossing USD 2.18 billion revenue by 2035.
North America inhalation capsules market will secure over 38% share by 2035, driven by a well-established healthcare system and advanced research facilities.
Key players in the market include Cipla, GSK(GlaxoSmithKline), Hovione, Chiesi, Iconovo, Novartis, ACG, Norton Healthcare, Capsugel, OPKO.
